Results for all evidence | Prescribing and Technical Information | Scottish Medicines Consortium - SMC 1 - 10 of 1688 sorted by relevance / date

Indication: AstraZeneca UK Ltd

Indication: For the adjunctive treatment of primary generalised tonic-clonic seizures in adult and adolescent patients from 12 years of age with idiopathic generalised epilepsy.

Indication: Sanofi

Indication: In combination with methotrexate for the treatment of polyarticular juvenile idiopathic arthritis in children 2 years of age and older who have responded inadequately to previous therapy...

Indication: Treatment of adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma in combination with doxorubicin, vinblastine and dacarbazine.

Indication: In adults with established atherosclerotic cardiovascular disease to reduce cardiovascular risk by lowering LDL-C levels, as an adjunct to correction of other risk factors: • in...

Indication: For the treatment of hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Indication: Unresectable locally advanced squamous cell carcinoma of the head and neck

Indication: Operable, node-positive breast cancer.

Indication: Hormone refractory metastatic prostate cancer.